Neonatal & Pediatric Intensive Care2024-04-04T18:50:55+00:00

Noninvasive monitoring should enable less invasive care – especially for the most delicate patients.

Noninvasive monitoring should enable less invasive care – especially for the most delicate patients.

Noninvasive monitoring should enable less invasive care – especially for the most delicate patients.

TRANSCUTANEOUS MONITORING (TCM)

Optimize ventilation while reducing blood draws

Continuous, accurate CO2 values that help titrate ventilation and deliver less invasive care through blood draw reduction.

ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT)

Assess regional lung function at the bedside​

Real-time regional lung function images inform ventilation strategies to help clinicians personalize care and achieve optimal outcomes.

Cluster care

Preserve skin integrity

CO2 monitoring can help clinicians determine effective ventilatory support

Characterize regional lung function​

Deliver personalized respiratory support​

TRANSCUTANEOUS MONITORING (TCM)

Optimize ventilation while reducing blood draws

Continuous, accurate CO2 values that help titrate ventilation and deliver less invasive care through blood draw reduction.

Cluster care

Preserve skin integrity

Deliver gentle, effective ventilation

ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT)

Assess regional lung function at the bedside​

Real-time regional lung function images inform ventilation strategies to help clinicians personalize care and achieve optimal outcomes.

Characterize regional lung function​

Deliver personalized respiratory support​

Deliver gentle, effective ventilation

TCM IN THE NICU

Balancing Brain & Lung Protection in the NICU with Transcutaneous CO2

Keeping your sights on CO2 values can help deliver the most gentle effective ventilatory support for the individual patient – support that protects the neonatal brain without damaging premature lungs.

TCM IN THE NICU

Balancing Brain & Lung Protection in the NICU with Transcutaneous CO2

Keeping your sights on CO2 values can help deliver the most gentle effective ventilatory support for the individual patient – support that protects the neonatal brain without damaging premature lungs.

Benefits for Patients

Site times up to 8 hours enable low stimulation protocols while continuous CO2 information helps safely reduce blood draws and heel sticks.

Low operating temperature and customized adhesion options protect fragile skin.

Non airway-dependent CO2 values are accurate regardless of ventilation modality or severity of lung compromise.

Benefits for Providers

Continuous, accurate CO2 values paired with site times up to 8 hours let you keep a close eye on these fragile patients while letting them be.

Transcutaneous technology provides accurate CO2 readings regardless of ventilation strategy, enabling enhanced assessment during de-escalation or accelerations in care or support.

Easy-to-learn technology and processes that enhance ventilatory management for individual patients.

Benefits for Facilities

Transcutaneous CO2 provides accurate ventilation information where end tidal can’t – even during high frequency and high flow ventilation methods as well as bubble CPAP and spontaneous breathing.

Continuous, accurate CO2 information allows for the safe reduction of blood draws and heel sticks, reducing hard costs as well as softer costs like pain, blood loss, transfusion, and infection.

AARC guidelines recommend transcutaneous monitoring for any patient on high frequency or high flow ventilation, as well as any patient who would benefit from minimal blood draws.

See the value for yourself.

At the end of the day, we know you need to see this product work in your unit, with your staff, on your patients. Requesting a demo is the first step to getting this technology in your hands for a thorough evaluation.

The Drawbacks of Blood Draws: Transcutaneous Technology Can Help

The implementation of transcutaneous monitoring in one NICU was associated with a 25% decrease in blood draws on ventilated patients.1 Learn more below about why reducing blood draws is an important initiative in neonatology.

  1. Mukhopadhyay S, Maurer R, Puopolo KM. Neonatal Transcutaneous Carbon Dioxide Monitoring–Effect on Clinical Management and Outcomes. Respir Care. 2016;61(1):90-97. doi:10.4187/respcare.04212

Explore TCM Products & Support

Learn more about transcutaneous monitoring technology or view our product resource library to support an existing system.

IPV THERAPY IN NEONATAL AND PEDIATRIC CARE

Airway clearance therapy for the delicate lungs of neonates and children

Sentec IPV Therapy is an effective, safe, and well-tolerated airway clearance therapy that restores gas exchange capacity for diverse respiratory patients. Adjustable settings place control in caregivers’ hands, enabling safe, customized therapy for patients in the NICU and PICU.

IPV THERAPY 

IN NEONATAL AND PEDIATRIC CARE

Airway clearance therapy for the delicate lungs of neonates and children

Sentec IPV Therapy is an effective, safe, and well-tolerated airway clearance therapy that restores gas exchange capacity for diverse respiratory patients. Adjustable settings place control in caregivers’ hands, enabling safe, customized therapy for patients in the NICU and PICU.

Benefits for Patients

Adjustable settings enable a smooth, gentle flow that supports a comfortable and safe therapy experience for even the most delicate patients.

IPV therapy is a clinically effective and well-tolerated treatment for a range of patient populations – including children with neuromuscular diseases, severe asthma, and bronchiolitis.

Benefits for Providers

Customizable settings can be adjusted based on respiratory condition, lung function, tolerance, and comfort, enabling clinicians to provide a tailored treatment to each patient.

IPV therapy can be delivered through a mouthpiece, mask, direct to the airway, or in-line with a ventilator, allowing for adaptable treatment delivery based on patient need.

Benefits for Facilities

IPV therapy combines secretion clearance, lung recruitment, and hyperinflation relief into a single treatment modality, enabling a streamlined treatment plan.

As a clinically effective airway clearance therapy, IPV therapy is associated with improved outcomes for patients that reduce costs for NICUs and PICUs.

EIT IN THE NICU

Real-time regional lung function monitoring at the bedside​

The LuMon™ System enables clinicians to assess regional lung function in neonates continuously at the bedside without radiation exposure.​

The LuMon™ System received an EC certificate in June 2020. The LuMon™ System is not currently for sale in the United States. Contact us to be notified when products become available in the US.

EIT IN THE NICU

Real-time regional lung function monitoring at the bedside

The LuMon™ System enables clinicians to assess regional lung function in neonates continuously at the bedside without radiation exposure.​

The LuMon™ System received an EC certificate in June 2020. The LuMon™ System is not currently for sale in the United States. Contact us to be notified when products become available in the US.

Benefits for Patients

The LuMon™ Belts offer outstanding next-to-skin comfort while providing a secure, adhesive-free application. 

The LuMon™ System may help decrease radiation exposure for fragile neonates by providing bedside assessment of regional lung function.

Benefits for Providers

See ventilation distribution change over time as treatments take effect; Visualize trends up to 24 hours.

The LuMon™ System uses unique lung models to provide insightful information while automatically tracking patient position. 

Benefits for Facilities

The LuMon™ System offers clinicians regional lung function information to better assess a clinical scenario or impact of a medical intervention. 

The LuMon™ System can help inform care at transition points – empowering clinicians with more information at hand when deciding on a ventilation strategy, supporting the goal of choosing less invasive care when possible.

The LuMon™ Belts, Sentec’s textile EIT belts for neonates/infants, were clinically validated in a multi-center study on 200 neonates and infants (mean gestational age of 31±5 weeks; range: 24-42 weeks) within the European Union Horizon 2020 CRADL project, of which Sentec was part.

The LuMon™ Belts, Sentec’s textile EIT belts for neonates/infants, were clinically validated in a multi-center study on 200 neonates and infants (mean gestational age of 31±5 weeks; range: 24-42 weeks) within the European Union Horizon 2020 CRADL project, of which Sentec was part.

The LuMon™ Belts, Sentec’s textile EIT belts for neonates/infants, were clinically validated in a multi-center study on 200 neonates and infants (mean gestational age of 31±5 weeks; range: 24-42 weeks) within the European Union Horizon 2020 CRADL project, of which Sentec was part.

Care with Confidence

North American Inquiries:

customerservice.us@sentec.com

United Kingdom Inquiries:

customerservice.uk@sentec.com

Switzerland Inquiries:

customerservice@sentec.com

Education

Explore all of Sentec’s educational and product resources.

Quality

We adhere to the highest standards in the medical device industry. View and download our quality certificates here.

Distributor Resources

Current distributors of Sentec technology can log in here to access training, resources, and materials.

Australian Inquiries:

customerservice.au@sentec.com

Austrian Inquiries:

customerservice.at@sentec.com

German Inquiries:

customerservice.de@sentec.com

Japan Inquiries:

customerservice.jp@sentec.com

Turkey:

customerservice.tr@sentec.com

All Other Inquiries:

info@sentec.com

Careers

Explore options and pathways to join our innovative and collaborative team.

Other Products

Learn more about other products supported by the Sentec team.

About

Learn more about our mission, our vision, and our team.

© Copyright 2023 Sentec AG | Imprint | Legal Disclaimer | Privacy Policy | United Kingdom Sustainability